All Stories

  1. The HGR motif is the antiangiogenic determinant of vasoinhibin: implications for a therapeutic orally active oligopeptide
  2. Development of Vasoinhibin-Specific Monoclonal Antibodies
  3. Time for a New Perspective on Prolactin in Metabolism
  4. Matrix Metalloproteases and Cathepsin D in Human Serum do not Cleave Prolactin to Generate Vasoinhibin
  5. Improving Immunotherapy Against B-Cell Malignancies Using γδ T-Cell–specific Stimulation and Therapeutic Monoclonal Antibodies
  6. Analysing Point Mutations in Protein Cleavage Sites by Using Enzyme Specificity Matrices
  7. Regulator of Angiogenesis and Vascular Function: A 2019 Update of the Vasoinhibin Nomenclature
  8. Vasoinhibin comprises a three-helix bundle and its antiangiogenic domain is located within the first 79 residues
  9. Basis and Design of a Randomized Clinical Trial to Evaluate the Effect of Levosulpiride on Retinal Alterations in Patients With Diabetic Retinopathy and Diabetic Macular Edema
  10. Osteoarthritis and the Complement Cascade
  11. From Bench to Bedside: Translating the Prolactin/Vasoinhibin Axis
  12. Human Prolactin Point Mutations and Their Projected Effect on Vasoinhibin Generation and Vasoinhibin-Related Diseases
  13. Vasoinhibins May Contribute to Postpartum Depression
  14. Percutaneous Closure of Left Atrial Appendage affects Mid-Term Release of MR-proANP
  15. Commentary: Prolactin Alters Blood Pressure by Modulating the Activity of Endothelial Nitric Oxide Synthase
  16. Remarks on the Prolactin Hypothesis of Peripartum Cardiomyopathy
  17. Vasoinhibin Serum Levels Are Required to Demonstrate Their Role in Peripartum Cardiomyopathy Etiopathology
  18. Comment On: Peripartum Cardiomyopathy Treatment with Dopamine Agonist and Subsequent Pregnancy with a Satisfactory Outcome
  19. Higher prolactin and vasoinhibin serum levels associated with incidence and progression of retinopathy of prematurity
  20. The vasoinhibin solution structure appears unfolded, dynamic, and features aggregation
  21. Serum proteases do not cleave prolactin to vasoinhibins at physiological pH
  22. Principles of the prolactin/vasoinhibin axis
  23. C-reactive protein and the acute phase reaction in geriatric patients
  24. On the Path toward Classifying Hormones of the Vasoinhibin-Family
  25. Vitamin D deficiency decreases survival of bacterial meningoencephalitis in mice
  26. High Prolactin Excretion in Patients with Diabetes Mellitus and Impaired Renal Function
  27. Regulation of Blood Vessels by Prolactin and Vasoinhibins
  28. Vasoinhibins are natural inhibitors of angiogenesis in the vitreous and are impaired in patients with diabetic retinopathy
  29. Alpha-1-Fetoprotein (AFP) Measurements and the High-Dose Hook Effect
  30. Prolactin promotes normal liver growth, survival, and regeneration in rodents: effects on hepatic IL-6, suppressor of cytokine signaling-3, and angiogenesis
  31. Prolactin promotes cartilage survival and attenuates inflammation in inflammatory arthritis
  32. Comment on: Richter et al. Serum Levels of the Adipokine Progranulin Depend on Renal Function. Diabetes Care 2013;36:410-414
  33. Role of IGF‐1 and glycaemic control in diabetic retinopathy
  34. Melanocortin receptors in rat liver cells: change of gene expression and intracellular localization during acute-phase response
  35. Prolactin and vasoinhibins: Endogenous players in diabetic retinopathy
  36. Investigation of prolactin-related vasoinhibin in sera from patients with diabetic retinopathy
  37. Nodal Dissection for Gastric Cancer